| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |